Lipid Lowering Drugs and Inflammatory Changes: An Impact on Cardiovascular Outcomes?

Annals of Medicine - United Kingdom
doi 10.1080/07853890.2018.1498118
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Informa UK Limited

Related search

Lipid-Lowering Drugs (Statins) and Peripheral Neuropathy

Electronic Physician
2018English

Adherence to Lipid Lowering Drugs in Patients With Schizophrenia

Clinical Therapeutics
Pharmacology
2017English

Diabetic Outcomes: Cardiovascular Outcomes With Lipid modificationH 2D

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

Use of Antiepileptic Drugs and Lipid-Lowering Agents in the United States

Epilepsy and Behavior
NeurologyBehavioral Neuroscience
2014English

Guidelines Accompanied by Changes in Reimbursement rulesEffects on Lipid-Lowering Drug Prescribing

Scandinavian Journal of Primary Health Care
EnvironmentalPublic HealthOccupational Health
2001English

Use of Lipid Lowering Drugs in Primary Care Is Highly Variable

BMJ
1998English

Impact of Aspirin and Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs on Outcomes in Patients With Metastatic Renal Cell Carcinoma

Kidney Cancer
2018English

Should Women Be Offered Cholesterol Lowering Drugs to Prevent Cardiovascular Disease? Yes

BMJ
2007English

Effect of Lipid-Lowering Treatment in Cardiovascular Disease Prevalence in Familial Hypercholesterolemia

Atherosclerosis
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy